Effectiveness of Electroconvulsive Therapy for Preventing Relapse and Recurrence of Depression in Adults With Major Depressive Disorder: An Updated Meta-Analysis of Randomized Clinical Trials

被引:4
|
作者
Dar, Hassaan [1 ]
Vuthaluru, Kiranmayi [2 ]
Folajimi, Atunde [3 ]
Maheshwari, Leladher [4 ]
Shah, Jeet [5 ]
Senaratne, Mithum [6 ]
Pizzorno, Guiomarly [7 ]
Ali, Neelum [8 ]
机构
[1] Jinnah Med & Dent Coll, Res, Islamabad, Pakistan
[2] Jawaharlal Nehru Med Coll, Med, Belgaum, India
[3] NES Healthcare, Neurol, Aylesbury, England
[4] Bahria Univ, Med & Dent Coll, Med Sch, Karachi, Pakistan
[5] Sir Sayajirao Gen Hosp, Med & Surg, Ahmadabad, India
[6] Univ Ruhuna, Med, Matara, Sri Lanka
[7] Univ Carabobo, Gen Med, Orlando, FL USA
[8] Univ Hlth Sci, Internal Med, Lahore, Pakistan
关键词
meta; -analysis; recurrence; relapse; depression; electroconvulsive therapy; CONTINUATION TREATMENT; GUIDELINES; ECT; PHARMACOTHERAPY; EFFICACY; MOOD;
D O I
10.7759/cureus.35683
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The present meta-analysis aimed to assess the impact of electroconvulsive therapy (ECT) in preventing the relapse and recurrence of depression in adults with major depressive disorders. The study was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Two authors conducted a systematic search of online databases, such as PubMed, PsycINFO, and EMBASE, using keywords, such as "electroconvulsive therapy," "depressive disorders," and "recurrence." The primary outcome measure was the incidence of relapse and recurrence in adults with major depressive disorder who received ECT alone or in combination with an antidepressant medication compared to those who received antidepressant medication alone. The secondary outcome measure was the change in the Mini -Mental State Examination score from baseline to the end of the trial in both groups. A total of six articles were included in the meta-analysis. The pooled rate of recurrence in the ECT group was 28.4% compared to 30.6% in the antidepressant group, with no significant difference between the two groups (risk ratio (RR) = 0.84, 95% confidence interval (CI) = 0.65-1.10, p = 0.21). However, subgroup analysis showed that the risk of recurrence was significantly lower in patients receiving ECT with antidepressant therapy compared to the antidepressant group alone (RR = 0.65, 95% CI = 0.45-0.93, p = 0.02). On the other hand, when ECT was given alone, the risk was higher in the ECT group compared to the antidepressant group; however, the difference was not statistically significant (RR = 1.17, 95% CI = 0.79-1.75). In conclusion, the results of this meta-analysis suggest that ECT alone or in combination with an antidepressant medication does not significantly impact the incidence of recurrence in adults with major depressive disorder when compared to antidepressant medication alone.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Esketamine Nasal Spray in Major Depressive Disorder: A Meta-Analysis of Randomized Controlled Trials
    Wang, Zhibin
    Jiang, Lili
    Ma, Wenzhuang
    Li, Xingyue
    Gao, Qiushi
    Lian, Siyu
    Yu, Weiwei
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2025,
  • [32] Statins for major depressive disorder: A systematic review and meta-analysis of randomized controlled trials
    De Giorgi, Riccardo
    De Crescenzo, Franco
    Rizzo Pesci, Nicola
    Martens, Marieke
    Howard, Wendy
    Cowen, Philip J.
    Harmer, Catherine J.
    PLOS ONE, 2021, 16 (03):
  • [33] Comparison of SSRIs and SNRIs in major depressive disorder: a meta-analysis of head-to-head randomized clinical trials
    Machado, M.
    Einarson, T. R.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2010, 35 (02) : 177 - 188
  • [34] Lithium in the prevention of relapse following successful electroconvulsive therapy for major depression: a systematic review and meta-analysis
    Lambrichts, S.
    Detraux, J.
    Vansteelandt, K.
    Obbels, J.
    Schrijvers, D.
    Sienaert, P.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2020, 40 : S257 - S258
  • [35] Adjunctive antidepressants for the treatment of bipolar depression: An updated meta-analysis of randomized clinical trials
    Shafiee, Arman
    Moltazemi, Hassan
    Amini, Mohammad Javad
    Gargari, Omid Kohandel
    Safari, Farima
    Abhari, Faeze Soltani
    Jafarabady, Kyana
    Bakhtiyari, Mahmood
    ASIAN JOURNAL OF PSYCHIATRY, 2024, 91
  • [36] Meta-analysis of placebo rates in major depressive disorder trials
    Stolk, P
    ten Berg, MJ
    Hemels, MEH
    Einarson, TR
    ANNALS OF PHARMACOTHERAPY, 2003, 37 (12) : 1891 - 1899
  • [37] Comparative effectiveness clinical trial of magnetic seizure therapy and electroconvulsive therapy in major depressive disorder
    El-Deeb, Fatma A.
    Gad, El-Sayed A.
    Kandeel, Ahmed A.
    Haiba, Amr A.
    Fathy, Sameh M.
    Peterson, Meghan M.
    Youssef, Nagy A.
    ANNALS OF CLINICAL PSYCHIATRY, 2020, 32 (04) : 239 - 248
  • [38] Vortioxetine versus reuptake inhibitors in adults with major depressive disorder: A systematic review and meta-analysis of randomized controlled trials
    Barbosa, Eduardo Cerchi
    da Silva, Giovanna Hanike Santos
    Sbardelotto, Angelo Eduardo Espindola
    Barroso, Douglas Carneiro
    de Lima, Fernanda Ribeiro
    Paez, Loyna Eua Flores E.
    Lanca, Saulo Bernardo
    Petrucci, Arthur Bezerra Cavalcanti
    Guimaraes, Felipe Bandeira de Melo
    Nascimento, Antonio Leandro
    ASIAN JOURNAL OF PSYCHIATRY, 2024, 101
  • [39] Ketamine in electroconvulsive therapy for depressive disorder: A systematic review and meta-analysis
    Ren, Li
    Deng, Jie
    Min, Su
    Peng, Lihua
    Chen, Qibin
    JOURNAL OF PSYCHIATRIC RESEARCH, 2018, 104 : 144 - 156
  • [40] Increased BDNF levels after electroconvulsive therapy in patients with major depressive disorder: A meta-analysis study
    Rocha, Renan Boeira
    Dondossola, Eduardo Ronconi
    Grande, Antonio Jose
    Colonetti, Tamy
    Ceretta, Luciane Bisognin
    Passos, Ives C.
    Quevedo, Joao
    da Rosa, Maria Ines
    JOURNAL OF PSYCHIATRIC RESEARCH, 2016, 83 : 47 - 53